87 related articles for article (PubMed ID: 22382638)
1. Curcumin analog A13 alleviates oxidative stress by activating Nrf2/ARE pathway and ameliorates fibrosis in the myocardium of high-fat-diet and streptozotocin-induced diabetic rats.
Xiang L; Zhang Q; Chi C; Wu G; Lin Z; Li J; Gu Q; Chen G
Diabetol Metab Syndr; 2020; 12():1. PubMed ID: 31921358
[TBL] [Abstract][Full Text] [Related]
2. Very low-density lipoprotein (VLDL)-induced signals mediating aldosterone production.
Tsai YY; Rainey WE; Bollag WB
J Endocrinol; 2017 Feb; 232(2):R115-R129. PubMed ID: 27913572
[TBL] [Abstract][Full Text] [Related]
3. Pressure overload-induced cardiac hypertrophy response requires janus kinase 2-histone deacetylase 2 signaling.
Ying H; Xu MC; Tan JH; Shen JH; Wang H; Zhang DF
Int J Mol Sci; 2014 Nov; 15(11):20240-53. PubMed ID: 25380525
[TBL] [Abstract][Full Text] [Related]
4. Genetic studies in mice and humans reveal new physiological roles for the high-density lipoprotein receptor scavenger receptor class B type I.
Hoekstra M; Van Eck M; Korporaal SJ
Curr Opin Lipidol; 2012 Apr; 23(2):127-32. PubMed ID: 22262054
[TBL] [Abstract][Full Text] [Related]
5. Roles of scavenger receptor BI and APO A-I in selective uptake of HDL cholesterol by adrenal cells.
Williams DL; Temel RE; Connelly MA
Endocr Res; 2000 Nov; 26(4):639-51. PubMed ID: 11196441
[TBL] [Abstract][Full Text] [Related]
6. Modified high-density lipoprotein modulates aldosterone release through scavenger receptors via extra cellular signal-regulated kinase and Janus kinase-dependent pathways.
Saha S; Graessler J; Schwarz PE; Goettsch C; Bornstein SR; Kopprasch S
Mol Cell Biochem; 2012 Jul; 366(1-2):1-10. PubMed ID: 22382638
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk Between Glycoxidative Modification of Low-Density Lipoprotein, Angiotensin II-Sensitization, and Adrenocortical Aldosterone Release.
Saha S; Bornstein SR; Graessler J; Kopprasch S
Horm Metab Res; 2015 Oct; 47(11):855-60. PubMed ID: 25602349
[TBL] [Abstract][Full Text] [Related]
8. Very-low-density lipoprotein mediates transcriptional regulation of aldosterone synthase in human adrenocortical cells through multiple signaling pathways.
Saha S; Bornstein SR; Graessler J; Kopprasch S
Cell Tissue Res; 2012 Apr; 348(1):71-80. PubMed ID: 22331364
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of phagocyte adhesion to endothelial cells by modified VLDL and HDL requires scavenger receptor BI.
Saha S; Graessler J; Bornstein SR; Schwarz PE; Kopprasch S
Mol Cell Biochem; 2013 Nov; 383(1-2):21-8. PubMed ID: 23852455
[TBL] [Abstract][Full Text] [Related]
10. [Not Available].
Saha S; Bornstein SR; Graessler J; Chakrabarti S; Kopprasch S
Horm Metab Res; 2017 Sep; 49(9):716-718. PubMed ID: 28834964
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II promotes selective uptake of high density lipoprotein cholesterol esters in bovine adrenal glomerulosa and human adrenocortical carcinoma cells through induction of scavenger receptor class B type I.
Cherradi N; Bideau M; Arnaudeau S; Demaurex N; James RW; Azhar S; Capponi AM
Endocrinology; 2001 Oct; 142(10):4540-9. PubMed ID: 11564720
[TBL] [Abstract][Full Text] [Related]
12. Aldosterone production in human adrenocortical cells is stimulated by high-density lipoprotein 2 (HDL2) through increased expression of aldosterone synthase (CYP11B2).
Xing Y; Cohen A; Rothblat G; Sankaranarayanan S; Weibel G; Royer L; Francone OL; Rainey WE
Endocrinology; 2011 Mar; 152(3):751-63. PubMed ID: 21239432
[TBL] [Abstract][Full Text] [Related]
13. Modulation of adrenal aldosterone release by oxidative modification of low-density lipoprotein.
Ansurudeen I; Pietzsch J; Graessler J; Ehrhart-Bornstein M; Saha S; Bornstein SR; Kopprasch S
Am J Hypertens; 2010 Oct; 23(10):1061-8. PubMed ID: 20559286
[TBL] [Abstract][Full Text] [Related]
14. Cellular cholesterol delivery, intracellular processing and utilization for biosynthesis of steroid hormones.
Hu J; Zhang Z; Shen WJ; Azhar S
Nutr Metab (Lond); 2010 Jun; 7():47. PubMed ID: 20515451
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
